Attila A. Priplata,Joseph P. Errico,John T. Raffle,Jonathan David Gardiner
申请号:
US15083174
公开号:
US20160206460A1
申请日:
2016.03.28
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The present invention provides systems and methods for treating and controlling obesity and/or type II diabetes. In one aspect of the invention, a device comprises a hollow sleeve sized and shaped for positioning within a duodenum of the patient, an anchor coupled to the proximal end of the sleeve and being sized and shaped to inhibit distal migration of the sleeve and a plurality of elastomeric objects coupled to the distal end of the sleeve and being sized and shaped to inhibit proximal migration of the sleeve through a pylorus of the patient. The bypass device can be placed and removed endoscopically through the patients esophagus in a minimally invasive outpatient procedure and it is “self-anchoring” and does not require invasive tissue fixation within the patients GI tract, thereby reducing collateral tissue damage and minimizing its impact on the digestive process.